ema glp-1 vision loss recommendation 2025 finds no link between receptor agonists and suicidal thoughts Everything you need to know

Marginal structural models were used to evaluate the association between GLP-1RAs and MACE risk, accounting for time-varying confounding using inverse probability weighting, although residual confounding cannot be fully excluded

95% CI, -0.44 to -0.10) and hemoglobin A1c reduction (SGLT2i: mean difference, -0.33%

Discontinued treatment, low maintenance dosage led to reduced effectiveness of GLP-1 medications on body weight and blood sugar levels A Cleveland Clinic study shows that semaglutide and tirzepatide injectable GLP-1 drugs for obesity produce smaller weight loss in a real-world setting because patients discontinue treatment or use lower maintenance dosages

Retinopathy may transiently worsen with rapid glucose lowering (semaglutide)